We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics- Hematology Division


Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Biomarkers of the Humoral Immune System and Inflammation Assessed

By LabMedica International staff writers
Posted on 25 Sep 2021
Print article
The Roche Hitachi 911 Chemistry Analyzer (Photo courtesy of GMI
The Roche Hitachi 911 Chemistry Analyzer (Photo courtesy of GMI
The immune system is a complex set of physiological mechanisms that defend the body against infectious agents (bacteria, viruses, parasites, fungi) that can cause disease. Immunological surveillance can also detect and eliminate cancer cells.

Macrophages conduct the defense against bacteria and fungi, but also by acting as antigen-presenting cells to trigger adaptive immunity and as effector cells in antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis (ADCP). Cytokines and chemokines released by macrophages in response to pathogen constituents initiate the process known as inflammation.

Medical Scientists at the King’s College London (London, UK) and their colleagues explored the reciprocity between the humoral immune system and inflammation and assessed how external socio-demographic factors may influence these interactions. Inclusion criteria for their study were defined as follows: all individuals aged 20 or older and with the following measurements (n = 5513): immunoglobulin A (IgA), immunoglobulin G (IgG), immunoglobulin M (IgM), C-reactive protein (CRP), haptoglobin, albumin, white blood cells (WBC), serum iron (SI) and total iron-binding capacity (TIBC).

The quantitative determination of IgA, IgG and IgM was done with a turbidimetric determination with reagents (DAKO, Glostrup, Denmark) using a HITACHI 911 automatic analyzer (Boehringer, Mannheim, Germany). Serum CRP and haptoglobin was measured with an immunoturbidimetric assay using the fully automated DAX 96 multichannel analyzer (Technicon Instruments Corporation, Tarrytown, NY, USA). Albumin was measured using the bromocresol green method. Leukocytes were measured by routinely used hematology analyzers (STKS Haematology System from Coulter Corporation, Hialeah, FL, USA).

The team reported that frequently used serum markers for inflammation, CRP, haptoglobin and white blood cells, correlated together. Hierarchical clustering and principal component analysis confirmed the interaction between these main biological responses, showing an acute response component (CRP, Haptoglobin, WBC, IgM) and adaptive response component (Albumin, Iron, TIBC, IgA, IgG). A socioeconomic gradient associated with worse health outcomes was observed, specifically low educational level, older age and male sex were associated with serum levels that indicated infection and inflammation.

The authors concluded that their findings indicate that serum markers of the humoral immune system and inflammation closely interact in response to infection or inflammation. Clustering analysis presented two main immune response components: an acute and an adaptive response, comprising markers of both biological pathways. Future studies should shift from single internal marker assessment to multiple humoral and inflammation serum markers combined, when assessing risk of clinical outcomes such as cancer. The study was published on September 6, 2021 in the journal BMC Immunology.

Related Links:

King’s College London >>> www.kcl.ac.uk
DAKO >>> www.dako.de
Technicon Instruments
Coulter Corporation 

Gold Supplier
Lactate Dehydrogenase (LDH) Assay
Tuberculosis (TB) Test
QIAreach QuantiFERON-TB
Gold Supplier
TBI Blood Test
i-STAT TBI Plasma Test
Flu A/B Antibodies and Antigens
HyTest Flu A/B Antibodies and Antigens

Print article


Molecular Diagnostics

view channel
Image: Absence of nuclear immunohistochemical staining of MSH2 protein (A) and presence of MLH1 protein (B) in urothelial cell carcinoma of the urinary bladder of a patient carrying a germline MSH2 mutation. Observe the nuclear staining in stromal cells as an internal control (Photo courtesy of Radboud University Nijmegen Medical Centre)

Simple Urine Test Detects Urothelial Cancers in Lynch Syndrome Patients

Lynch Syndrome (LS) is an inherited genetic disorder that carries a high risk of cancer. LS is caused by mutations affecting MLH1, MSH2, MSH6 or PMS2 genes. More than one in 300 people have LS but most... Read more


view channel
Image: The Gazelle Hb Variant Test for screening, diagnosis and management of sickle cell disease and related hemoglobinopathies at the point of care (Photo courtesy of Hemex Health)

Point-of-Care Device Accurately Rapidly Diagnoses Sickle Cell Disease

Hemoglobinopathies are the most common autosomal hereditary disorders. Approximately 7% of the global population carries hemoglobin gene mutation including structural hemoglobin variants like sickle hemoglobin... Read more


view channel
Image: The sciREADER CL2 enables high quality digital colorimetric imaging of various support formats (Photo courtesy of SCIENION)

Multiplex Immunoassay Developed for Confirmation and Typing of HTLV Infections

Human T-Cell Lymphotropic Viruses (HTLV) type 1 and type 2 account for an estimated five to 10 million infections worldwide and are transmitted through breast feeding, sexual contacts and contaminated... Read more


view channel

AI Accurately Detects and Diagnoses Colorectal Cancer from Tissue Scans As Well or Better Than Pathologists

Artificial intelligence (A) can accurately detect and diagnose colorectal cancer from tissue scans as well or better than pathologists, according to a new study. The study, which was conducted by researchers... Read more


view channel
Image: PKeye Workflow Monitor System (Photo courtesy of PerkinElmer, Inc.)

PerkinElmer’s New Cloud-Based Platform Enables Laboratory Personnel to Remotely Manage Its Instruments in Real-Time

PerkinElmer, Inc. (Waltham, MA; USA) has launched its PKeye Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows... Read more


view channel

Global Point of Care Diagnostics Market to Top USD 35 Billion by 2027 Due to Rising Diabetic Cases

The global point of care diagnostics market is projected to grow at a CAGR of close to 6% from more than USD 23 billion in 2020 to over USD 35 billion by 2027, driven by an increase in the number of diabetic... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.